نتایج جستجو برای: morphine potency

تعداد نتایج: 40586  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1981
R W McLawhon R E West R J Miller G Dawson

The high-affinity binding of benzomorphan drugs (ethylketocyclazocine and N-allylnorcyclazocine) and [DAla2,DLeu5] enkephalin was examined in a mouse neuroblastoma--Chinese hamster brain clonal hybrid cell line (NCB-20). Scatchard analysis of saturation binding isotherms indicated the presence of a single binding site for 3H-labeled [DAla2,DLeu5]enkephalin (Kd = 3 nM) and multiple binding sites...

2010
S.O. Mashayekhi M. Ghandforoush-Sattari D.C. Buss P.A. Routledge R.DW. Hain

BACKGROUND AND THE PURPOSE OF THE STUDY The aim of the present study was to examine factors that may influence the protein binding of morphine 6-glucuronide (M6G), the most active metabolite of morphine. METHODS An enzyme-linked immunoabsorbent assay technique was used to measure the M6G concentration in serum of 18 healthy adults, 18 neonatal and 7 children with cancer. Total and free M6G co...

Journal: :Life sciences 2009
Glenn W Stevenson Jim Cormier Hannah Mercer Chloe Adams Catherine Dunbar S Stevens Negus Edward J Bilsky

AIMS Pain depresses expression of many behaviors, and one goal of analgesic treatment is to restore pain-depressed behaviors. Assays that focus on pain-depressed behaviors may contribute to preclinical assessment of candidate analgesics. MAIN METHODS This study compared effects of the mu opioid receptor agonist morphine (an acknowledged analgesic), the dopamine receptor antagonist haloperidol...

2013
Sarah A. Nickolls Sian Humphreys Mellissa Clark Gordon McMurray

Agonists at the µ-opioid receptor are known to produce potent analgesic responses in the clinical setting, therefore, an increased understanding of the molecular interactions of ligands at this receptor could lead to improved analgesics. As historically morphine has been shown to be a poor recruiter of β-arrestin in recombinant cell systems and this can be overcome by the co-expression of GRK2,...

Journal: :The New Zealand medical journal 2015
Leo J Schep Robin J Slaughter

Overseas investigations have shown that many healthcare institutions are understocked of antidotes to treat these patients. 1–4 Despite a recent study to the contrary, 5 the paper by Fountain and colleagues, published in this issue of the New Zealand Medical Journal, suggests similar problems in New Zealand hospitals with shortcomings in hospital pharmacy stocks and resupply. 6 The paper raises...

Journal: :The Journal of pharmacology and experimental therapeutics 2015
Ahmad A Altarifi Kenner C Rice S Stevens Negus

Pain is associated with stimulation of some behaviors and depression of others, and μ-opioid receptor agonists are among the most widely used analgesics. This study used parallel assays of pain-stimulated and pain-depressed behavior in male Sprague-Dawley rats to compare antinociception profiles for six μ-agonists that varied in efficacy at μ-opioid receptors (from highest to lowest: methadone,...

Journal: :The Journal of pharmacology and experimental therapeutics 2003
Andrew C Barrett Eric S Smith Mitchell J Picker

The influence of sex in determining responses to opioid analgesics has been well established in rodents and monkeys in assays of short-lasting, phasic pain. The purpose of this investigation was to use a capsaicin model of tonic pain to evaluate sex differences in hyperalgesia and mu-opioid-induced antihyperalgesia in Fischer 344 (F344) rats. Capsaicin injected into the tail produced a dose-dep...

2014
Tanila Ben Haddou Davide Malfacini Girolamo Calo Mario D Aceto Louis S Harris John R Traynor Andrew Coop Helmut Schmidhammer Mariana Spetea

BACKGROUND Opioid analgesics are the most effective drugs for the treatment of moderate to severe pain. However, they also produce several adverse effects that can complicate pain management. The μ opioid (MOP) receptor, a G protein-coupled receptor, is recognized as the opioid receptor type which primarily mediates the pharmacological actions of clinically used opioid agonists. The morphinan c...

Journal: :The Journal of pharmacology and experimental therapeutics 2009
Ellen E Codd John R Carson Raymond W Colburn Dennis J Stone Christopher R Van Besien Sui-Po Zhang Paul R Wade Elizabeth L Gallantine Theo F Meert Lory Molino Shirley Pullan Christine M Razler Scott L Dax Christopher M Flores

Mu-opioid analgesics are a mainstay in the treatment of acute and chronic pain of multiple origins, but their side effects, such as constipation, respiratory depression, and abuse liability, adversely affect patients. The recent demonstration of the up-regulation and membrane targeting of the delta-opioid receptor (DOR) following inflammation and the consequent enhanced therapeutic effect of de...

2014
Ahmad A. Altarifi Kenner C. Rice S. Stevens Negus

Pain is associated with stimulation of some behaviors and depression of others, and m-opioid receptor agonists are among the most widely used analgesics. This study used parallel assays of pain-stimulated and pain-depressed behavior in male SpragueDawley rats to compare antinociception profiles for six m-agonists that varied in efficacy at m-opioid receptors (from highest to lowest: methadone, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید